Home > Boards > US Listed > Biotechs > BELLUS Health Inc. (BLUSF)

Neurochem to Change Name and Ticker; Stock Up

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
surf1944 Member Profile
 
Followed By 438
Posts 24,814
Boards Moderated 3
Alias Born 09/11/06
160x600 placeholder
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 9/25/2019 6:01:06 AM
Statement of Beneficial Ownership (sc 13d) Edgar (US Regulatory) - 9/18/2019 4:17:39 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 9/17/2019 4:16:11 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 9/17/2019 11:05:41 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 9/16/2019 10:53:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 9/9/2019 9:28:32 AM
Voluntary Supplemental Material Filed Pursuant to Section 11(a) of the Securities Act of 1933 by Foreign Issuers (suppl) Edgar (US Regulatory) - 9/5/2019 3:53:52 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 9/5/2019 7:39:28 AM
Certification by the Exchange Approving Securities for Listing (cert) Edgar (US Regulatory) - 9/4/2019 5:01:51 PM
Amended Registration Statement for Securities of Certain Canadian Issuers Under the Securities Act of 1933 (f-10/a) Edgar (US Regulatory) - 9/4/2019 4:45:14 PM
Securities Registration (section 12(b)) (8-a12b) Edgar (US Regulatory) - 9/3/2019 8:18:20 AM
Appointment of Agent for Service of Process and Undertaking (f-x) Edgar (US Regulatory) - 9/3/2019 8:10:18 AM
Registration Statement for Securities of Certain Canadian Issuers Under the Securities Act of 1933 (f-10) Edgar (US Regulatory) - 9/3/2019 7:54:49 AM
Amended Small Company Offering and Sale of Securities Without Registration (d/a) Edgar (US Regulatory) - 1/29/2019 10:29:52 AM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 1/11/2019 11:25:48 AM
surf1944   Wednesday, 04/16/08 08:00:16 AM
Re: None
Post # of 261 
Neurochem to Change Name and Ticker; Stock Up

Neurochem Inc. (NRMX) shares were up more than 17% on Tuesday morning as shareholders settle in at the company's annual and special meeting in downtown Montreal where they will usher in a new era for the company.

Shareholders will be asked to officially adopt Neurochem's new name, BELLUS Health Inc., which it expects to start using on April 21, 2008, together with the new stock ticker symbols [TSX/BLU, BLUS/NASDAQ].

Neurochem will also present the launch activities that are in preparation for VIVIMIND [TM], the first branded natural health product to be marketed by its new, wholly-owned, nutraceutical subsidiary, OVOS Natural Health Inc., to protect memory function.

Shareholders will also learn that Neurochem has regained full ownership rights and control on eprodisate (KIACTA [TM]) from Centocor Inc., a wholly-owned subsidiairy of Johnson and Johnson (JNJ), for the prevention and treatment of Amyloid A [AA] amyloidosis.

http://seekingalpha.com/article/72464-neurochem-to-change-name-and-ticker-stock-up?source=yahoo


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist